Evonik is one of the world's leading specialty chemicals companies. Profitable growth and sustained value creation form the heart of our strategy. Around 80 percent of sales come from leading market positions, which we plan to expand further. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization.
In 2012 Evonik’s roughly 33,000 employees generated sales of €13.6 billion and an operating result (adjusted EBITDA) of €2.6 billion. 75 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
Evonik has defined this sector as a strategic core business. As such, we focus much of our energy on this area – and on our customers. For 40 years, we’ve been creating value for our health care customers by developing lasting solutions for the future. Our solutions for health care industry are ranging from the manufacturing of active pharmaceutical ingredients (APIs) to drug delivery system, and also include special polymers for medical technologies.
Evonik aims to provide localized and customized solutions for our local customers in health care industry, catering to the market trends and needs of Chinese healthcare industry. Our products and services revolve around a partnership-driven approach and synergic technologies: solutions are developed in partnerships and services are integral part of the business model.
About High Performance Polymers
Evonik High Performance Polymers takes customized products as the core competence. We provide customers with the professional technical support and product solutions.
Our products serials:
- High Performance Plastics
- Powders, Rubber and Building Blocks
C8 and C12 Rings
- Semi-Finished Products